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Abstract
In this paper, we describe the underlying methodology behind dis-
covery radiomics, where the ultimate goal is to discover customized,
abstract radiomic feature models directly from the wealth of med-
ical imaging data to better capture highly unique tumor traits be-
yond what can be captured using hand-crafted radiomic feature
models. We further explore the current state-of-the-art in discov-
ery radiomics and their application to various forms of cancer such
as prostate cancer and lung cancer, and show that discovery ra-
diomics can yield significant potential clinical impact.
1 Introduction
Radiomics [1, 2], which involves the high-throughput extraction and
analysis of a large amount of quantitative features from medical
imaging data to characterize tumor phenotypes in a quantitative
manner, is ushering in a new era of imaging-driven quantitative
personalized cancer decision support and management. A large
number of studies have been conducted showing the efficacy of
radiomics for various forms of cancers such as lung [1, 3], head-
and-neck [3], and prostate [4, 5].
While extremely powerful with the potential to make a tremen-
dous clinical impact, one of the limitations of the current state of ra-
diomics is that they rely entirely on existing, hand-crafted imaging-
based feature models based on aspects such as intensity, texture,
and shape. This can greatly limit its ability to fully characterize
the unique traits of different forms of cancer that may be not well
characterized by such hand-crafted feature models. As such, an
alternative strategy for identifying and uncovering imaging-based
feature models that are tailored to characterizing such unique tu-
mor phenotypes is highly desired.
Motivated to take radiomics to the next level in personalized
cancer quantification and characterization of unique tumor pheno-
types for different forms of cancer, the novel concept of discovery
radiomics was introduced, where the notion of predefined, hand-
crafted radiomic feature models is forgone in favor of discover-
ing customized, abstract radiomic feature models directly from the
wealth of medical imaging data already available for different forms
of cancer. Discovery radiomics enables an unprecedented level
of understanding and characterization of the unique cancer phe-
notypes associated with different forms of cancer, allowing for the
identification of a large amount of abstract imaging-based features
that capture highly unique tumor traits and characteristics beyond
what can be captured using predefined feature models.
In this paper, we will describe the underlying methodology be-
hind discovery radiomics in hopes of providing insights on its effi-
cacy for improved quantification of tumor phenotypes that is fully
tailored for specific forms of cancer, as well as further explore the
current state-of-the-art in discovery radiomics and their application
to various forms of cancer.
2 Methodology
The general discovery radiomics framework consists of the follow-
ing key steps (see Fig. 1). First, a wealth of standardized medical
imaging data from past patients are fed into a radiomic sequencer
discovery process, where a customized radiomic sequencer is con-
structed based on a large number of customized, abstract radiomic
features that were discovered to capture highly unique tumor traits
and characteristics tailored for a particular form of cancer. Second,
for a new patient case, the discovered radiomic sequencer is then
used to extract a radiomic sequence composed of customized, tai-
lored imaging-based features from the medical imaging data of the
new patient case for comprehensive, custom quantification of the
tumor phenotypes.
3 Results and Discussion
Given the potential of discovery radiomics in delivering a more
comprehensive quantification of cancer phenotypes derived directly
Fig. 1: An overview of the general discovery radiomics framework
from the wealth of medical imaging data being collected by clini-
cians, a number of state-of-the-art discovery radiomics frameworks
have been investigated recently and have shown great promise
for application to various forms of cancer. Chung et al. [6] intro-
duced a discovery radiomics framework for prostate cancer de-
tection using multi-parametric MRI data. The framework revolves
around a very deep stochastic convolutional radiomic sequencer,
which is discovered using multi-parametric MRI data from past pa-
tients. Experimental results showed that the discovered radiomic
sequencer using [6] achieved an accuracy of 73.7% on a clinical
dataset, which exceeded the state-of-the-art radiomic sequencer
presented in [4]. Kumar et al. [7] introduced a discovery radiomics
framework for lung cancer detection using CT data. The frame-
work revolves around a convolutional radiomic sequencer, which is
discovered using a wealth of CT data from past patients. Experi-
mental results showed that the discovered radiomic sequencer us-
ing [7] achieved an accuracy of 77.52% on the LIDC-IDRI dataset
based on diagnostic results, which exceeded existing state-of-the-
art radiomic sequencers. It can be observed from these studies
that discovery radiomics can yield significant diagnostic benefits
and can have tremendous potential clinical impact.
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